Quanterix
About Quanterix
Aushon BioSystems provides protein biomarker measurement and analysis products and services via an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance with industry-leading ease-of-use. With a growing menu of more than 300 biomarkers in key therapeutic areas and advanced microarray printing technology, our comprehensive suite of products and services offers a complete solution for our customers - global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries. They trust us to provide the most reliable protein biomarker data available, in the least amount of time, to lower their costs and improve research productivity.Aushon's goal is to enable breakthroughs in biological research, drug discovery & development, and the treatment of disease by accelerating drug development, advancing life science research and enabling personalized medicine.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: Not available
- Total Funding: None None
- Last Funding: None None (None)
- Funding Status: None
Technology Stack
Quanterix actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Biotechnology
Headquarters: None
Leadership
- Samira Amini - SVP, Finance Ops & Chief of Staff to CEO LinkedIn
- Sibu Tshabalala - Senior Director, IT Business Partner Functions LinkedIn
- David Duffy - Chief Technology Officer and Vice President of Research LinkedIn
- Alexandra Phillips - SVP and Chief Information Officer LinkedIn
- Erica Bell - SVP, Chief People Officer LinkedIn
Employees
- Ahmed Hassan - Talent Acquisition Partner (LinkedIn)
- Daniel Pikora - Chief Operating Officer (LinkedIn)
- Darrin Crisitello - Chief Commercial Officer (CCO) (LinkedIn)
- Masoud Toloue - Chief Executive Officer (LinkedIn)
- Mike Doyle - Chief Financial Officer (LinkedIn)